SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 134 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $194,737 | -56.8% | 324,671 | -6.5% | 0.00% | – |
| Q2 2023 | $451,195 | -50.2% | 347,073 | -32.5% | 0.00% | – |
| Q1 2023 | $905,305 | -28.0% | 514,378 | +28.4% | 0.00% | – |
| Q4 2022 | $1,257,485 | -42.4% | 400,473 | -10.2% | 0.00% | -100.0% |
| Q3 2022 | $2,185,000 | +10.9% | 445,999 | -6.2% | 0.00% | 0.0% |
| Q2 2022 | $1,970,000 | -41.9% | 475,481 | -18.6% | 0.00% | 0.0% |
| Q1 2022 | $3,393,000 | -25.2% | 584,082 | -3.4% | 0.00% | 0.0% |
| Q4 2021 | $4,535,000 | -23.4% | 604,704 | -7.9% | 0.00% | 0.0% |
| Q3 2021 | $5,917,000 | -28.4% | 656,814 | -4.8% | 0.00% | -50.0% |
| Q2 2021 | $8,261,000 | +0.1% | 690,197 | +4.7% | 0.00% | 0.0% |
| Q1 2021 | $8,256,000 | -33.1% | 658,955 | -16.7% | 0.00% | -33.3% |
| Q4 2020 | $12,345,000 | +53.9% | 791,080 | -6.8% | 0.00% | +50.0% |
| Q3 2020 | $8,022,000 | +9.9% | 849,020 | +4.3% | 0.00% | 0.0% |
| Q2 2020 | $7,297,000 | +71.2% | 814,391 | +21.7% | 0.00% | +100.0% |
| Q1 2020 | $4,262,000 | -20.7% | 669,137 | +4.2% | 0.00% | 0.0% |
| Q4 2019 | $5,374,000 | -29.1% | 641,969 | -23.4% | 0.00% | -50.0% |
| Q3 2019 | $7,585,000 | -14.3% | 838,130 | +2.0% | 0.00% | -33.3% |
| Q2 2019 | $8,847,000 | +41.2% | 821,420 | +25.1% | 0.00% | +50.0% |
| Q1 2019 | $6,265,000 | -16.9% | 656,636 | +0.0% | 0.00% | -33.3% |
| Q4 2018 | $7,536,000 | -50.1% | 656,405 | -26.3% | 0.00% | -25.0% |
| Q3 2018 | $15,089,000 | +34.5% | 890,234 | +12.7% | 0.00% | +33.3% |
| Q2 2018 | $11,218,000 | +6.3% | 789,981 | +42.2% | 0.00% | 0.0% |
| Q1 2018 | $10,556,000 | +8.4% | 555,635 | -6.4% | 0.00% | 0.0% |
| Q4 2017 | $9,735,000 | +36.7% | 593,562 | +25.0% | 0.00% | +50.0% |
| Q3 2017 | $7,121,000 | +87.6% | 474,768 | +10.1% | 0.00% | +100.0% |
| Q2 2017 | $3,795,000 | +146.7% | 431,234 | +45.8% | 0.00% | – |
| Q1 2017 | $1,538,000 | +92.7% | 295,770 | +13.0% | 0.00% | – |
| Q4 2016 | $798,000 | -41.1% | 261,642 | -10.6% | 0.00% | – |
| Q3 2016 | $1,354,000 | -12.9% | 292,636 | +9.0% | 0.00% | -100.0% |
| Q2 2016 | $1,555,000 | -2.3% | 268,475 | +2.0% | 0.00% | 0.0% |
| Q1 2016 | $1,592,000 | -18.4% | 263,115 | +23.2% | 0.00% | 0.0% |
| Q4 2015 | $1,950,000 | +104.8% | 213,586 | +26.6% | 0.00% | – |
| Q3 2015 | $952,000 | -44.4% | 168,711 | +9.3% | 0.00% | -100.0% |
| Q2 2015 | $1,712,000 | -49.1% | 154,336 | -28.1% | 0.00% | 0.0% |
| Q1 2015 | $3,366,000 | +128.8% | 214,722 | +122.1% | 0.00% | 0.0% |
| Q4 2014 | $1,471,000 | +48.0% | 96,659 | +4.8% | 0.00% | – |
| Q3 2014 | $994,000 | -10.0% | 92,189 | +27.4% | 0.00% | – |
| Q2 2014 | $1,105,000 | +36.6% | 72,356 | +61.9% | 0.00% | – |
| Q1 2014 | $809,000 | -51.4% | 44,695 | -62.7% | 0.00% | -100.0% |
| Q4 2013 | $1,663,000 | +92.7% | 119,736 | +45.5% | 0.00% | – |
| Q3 2013 | $863,000 | +47.3% | 82,295 | +9.7% | 0.00% | – |
| Q2 2013 | $586,000 | – | 74,995 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,000,000 | $66,540,000 | 6.69% |
| FIC CAPITAL INC | 787,529 | $8,734,000 | 3.47% |
| RA Capital Management | 1,220,209 | $13,532,000 | 1.36% |
| PRINCETON CAPITAL MANAGEMENT INC | 114,120 | $1,266,000 | 0.67% |
| Perceptive Advisors | 800,000 | $8,872,000 | 0.53% |
| Cormorant Asset Management, LP | 361,000 | $4,003,000 | 0.53% |
| Highlander Capital Management, LLC | 43,500 | $482,000 | 0.43% |
| APEX CAPITAL, LLC | 439,900 | $4,878,000 | 0.42% |
| WASATCH ADVISORS LP | 3,091,386 | $34,283,000 | 0.37% |
| Baker Brothers Advisors | 3,230,932 | $35,831,000 | 0.31% |